Inogen launches Voxi 5 stationary oxygen concentrator for long-term care patients

Inogen launches Voxi 5 for long-term care patients: ©Sudok1 - stock.adobe.com

Inogen Inc. (Nasdaq: INGN), a manufacturer of medical technology focused on respiratory care, has announced the launch of its latest product, the Voxi 5 stationary oxygen concentrator, aimed at improving access to high-quality oxygen therapy for long-term care patients across the United States.

Designed in collaboration with Yuwell Medical, the Voxi 5 delivers continuous flow oxygen at one to five liters per minute in a compact, quiet, and mobile design. The device includes caster wheels for easy movement between rooms and offers advanced filtration via an eight-layer internal gas pathway. It also includes a three-year sieve bed warranty, reinforcing its value as a durable and affordable solution for home oxygen therapy.

“With Voxi 5, we are fulfilling our mission to make respiratory care more accessible and empowering for patients,” said Kevin Smith, president and Chief Executive Officer of Inogen. “This launch exemplifies our commitment to innovation, affordability, and enhancing the quality of life for those dependent on oxygen therapy.”

The Voxi 5 complements Inogen’s existing At Home product and provides an additional option for price-sensitive consumers or those requiring an extra unit for multi-room use.

Recent advances in home respiratory care

The release of the Voxi 5 underscores a broader trend of innovation in the home respiratory care market, where medical technology companies are responding to growing demand driven by aging populations and rising rates of chronic respiratory conditions such as COPD.

One major area of development is the integration of remote monitoring and telehealth compatibility into oxygen concentrators and related devices. Companies are now embedding sensors and connectivity features into their products, enabling real-time tracking of oxygen usage and performance, and allowing clinicians to adjust treatment plans without requiring in-person visits.

Another advancement is battery life and portability in portable oxygen concentrators. Newer models now offer extended battery duration—sometimes exceeding 10 hours—making them more viable for active patients. These devices are increasingly compact, airline-approved, and tailored to support a mobile lifestyle.

Meanwhile, improvements in noise reduction and filtration systems have made home oxygen concentrators less intrusive and more effective. Quieter devices like the Voxi 5 are crucial for ensuring a restful home environment, particularly for older adults and those with sleep disorders.